Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...

Mumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has ...

This study evaluates a new aqueous nasal formulation of ipratropium bromide (Atrovent Nasal Spray 0.03%) in subjects with perennial non-allergic rhinitis in a double-blind, placebo-controlled trial.

Lupin share price fell nearly 2 percent in the early trade on February 11 despite the company received United States Food and Drug Administration (USFDA) approval for nasal spray. At 09:23am ...

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for ...

Grasim Industries, the flagship entity of the Aditya Birla Group, posted a consolidated net loss of ₹ 168.7 crore for Q3 FY25 ...

Shares of Lupin Ltd dropped 2.8% despite a significant Q3 profit increase of 38.8% year-on-year. The company's revenue surged ...

Stocks including Eicher Motors, Lupin, MTAR Technologies, Aditya Birla Capital, Nykaa, Bata india, SBFC Finance, Samhi Hotels ...

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

The Indian stock market is set for an eventful session today, with Gift Nifty opening at 23,485.5 and currently trading 0.06% ...